Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IOVA

Iovance Biotherapeutics Inc

Sep 12 • 04:00PM ET

9.46

Dollar change +0.11
Percentage change 1.18	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI XBI IWM VB VBR VXF IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.68	Insider Own	18.58%	Shs Outstand	256.14M	Perf Week	-9.56%
Market Cap	2.87B	Forward P/E	-	EPS next Y	-0.72	Insider Trans	0.00%	Shs Float	247.13M	Perf Month	-11.92%
Income	-440.22M	PEG	-	EPS next Q	-0.30	Inst Own	68.27%	Short Float	23.34%	Perf Quarter	10.90%
Sales	32.77M	P/S	87.62	EPS this Y	31.97%	Inst Trans	-1.80%	Short Ratio	8.17	Perf Half Y	-35.78%
Book/sh	2.58	P/B	3.66	EPS next Y	44.22%	ROA	-51.14%	Short Interest	57.69M	Perf Year	58.72%
Cash/sh	1.36	P/C	6.96	EPS next 5Y	-	ROE	-65.36%	52W Range	3.21 - 18.33	Perf YTD	16.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.25%	ROI	-52.48%	52W High	-48.39%	Beta	0.65
Dividend TTM	-	Quick Ratio	4.85	Sales past 5Y	0.00%	Gross Margin	-124.49%	52W Low	194.70%	ATR (14)	0.66
Dividend Ex-Date	-	Current Ratio	5.15	EPS Y/Y TTM	25.12%	Oper. Margin	-1401.36%	RSI (14)	42.23	Volatility	7.74% 6.03%
Employees	557	Debt/Eq	0.11	Sales Y/Y TTM	13669.75%	Profit Margin	-1343.27%	Recom	1.50	Target Price	22.90
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	28.17%	Payout	-	Rel Volume	0.55	Prev Close	9.35
Sales Surprise	26.47%	EPS Surprise	3.82%	Sales Q/Q	12969.75%	Earnings	Aug 08 AMC	Avg Volume	7.06M	Price	9.46
SMA20	-12.79%	SMA50	0.40%	SMA200	-7.21%	Trades		Volume	3,968,165	Change	1.18%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-24	Downgrade	Piper Sandler	Overweight → Neutral	$19 → $10
Nov-20-23	Initiated	Goldman	Buy	$12
Sep-18-23	Reiterated	Barclays	Overweight	$40 → $18
May-30-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$11 → $17
Mar-27-23	Resumed	Wells Fargo	Equal Weight	$11
Jan-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$11 → $14
Dec-09-22	Downgrade	Goldman	Buy → Neutral	$20 → $6
Oct-31-22	Initiated	Guggenheim	Neutral
Aug-18-22	Resumed	Wells Fargo	Equal Weight	$14
Jan-28-22	Upgrade	Stifel	Hold → Buy	$23 → $25
Dec-07-21	Resumed	Cowen	Outperform
Jun-10-21	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$32
May-20-21	Downgrade	Piper Sandler	Overweight → Neutral	$35 → $18
May-19-21	Downgrade	Stifel	Buy → Hold
May-19-21	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
May-03-21	Initiated	Truist	Buy	$50
Apr-16-21	Initiated	Goldman	Buy	$97
Mar-08-21	Upgrade	H.C. Wainwright	Neutral → Buy	$50
Dec-15-20	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-06-20	Downgrade	Wells Fargo	Overweight → Equal Weight

Show Previous Ratings

Sep-06-24 09:30AM	This Is the Biggest Risk With Iovance Biotherapeutics Stock (Motley Fool)
Sep-03-24 05:00PM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire) -6.95%
Sep-02-24 06:15PM	3 Monster Biotech Stocks to Buy Before 2025 (Motley Fool)
Aug-27-24 04:36AM	Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? (Motley Fool)
Aug-16-24 05:00PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +6.57%
07:15AM	Loading…
Aug-14-24 07:15AM	This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock (Motley Fool) -5.87%
Aug-09-24 12:23PM	Why Iovance Biotherapeutics Shares Are Soaring Today (Motley Fool) +24.94%
09:27AM	Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View (Zacks)
Aug-08-24 05:30PM	Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.32%
04:24PM	Iovance Biotherapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024 (GlobeNewswire)
Aug-01-24 10:01AM	Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -6.53%
Jul-31-24 05:31AM	Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell? (Motley Fool)
Jul-29-24 06:24PM	Why Iovance Biotherapeutics Stock Stumbled Today (Motley Fool)
04:01PM	Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024 (GlobeNewswire)
08:31AM	Loading…
08:31AM	Heres Why Iovance Biotherapeutics (IOVA) Declined in Q2 (Insider Monkey)
Jul-19-24 05:00PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-17-24 02:29PM	7 Death Cross Stocks That Could Be Contrarian Buys (InvestorPlace)
Jul-14-24 05:45AM	Is Iovance Biotherapeutics a Millionaire Maker? (Motley Fool)
Jul-11-24 02:23PM	3 Under-$10 Biotech Stocks That Could Make You Rich (InvestorPlace) +8.48%
Jul-08-24 06:46PM	Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts? (Insider Monkey)
12:30PM	10 Most Shorted Stocks That Are Loved by Analysts (Insider Monkey)
Jun-28-24 07:00AM	Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma (GlobeNewswire)
04:05AM	Is It Too Late to Buy Iovance Biotherapeutics Stock? (Motley Fool)
Jun-21-24 05:00PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
06:36AM	3 Top Penny Stocks to Skyrocket Your Wealth in 2024 (InvestorPlace)
Jun-20-24 10:02PM	Is WSJ the Best Stock Analysis Website? (Insider Monkey)
08:47PM	15 Best Websites To Research Stocks (Insider Monkey)
Jun-10-24 10:15AM	The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why (Motley Fool)
May-29-24 06:20AM	What Makes e.l.f. Beauty (ELF) an Investment Bet? (Insider Monkey)
04:58AM	Loading…
04:58AM	Should You Consider Adding SharkNinja (SN) to Your Portfolio? (Insider Monkey)
May-28-24 08:14AM	Iovance Biotherapeutics (IOVA) Shares Rallied after the FDA approval of AMTAGVI (Insider Monkey)
08:06AM	Artisan Partners Small Cap Fund Trimmed Wingstop (WING) Based on Valuation Discipline (Insider Monkey)
May-24-24 04:01PM	Iovance Biotherapeutics to Present at Upcoming Conferences and Events (GlobeNewswire)
11:18AM	Iovance (IOVA) Up 5% on Updated Data From Melanoma Study (Zacks)
May-23-24 05:00PM	Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting (GlobeNewswire)
May-22-24 06:40AM	Bull Market Buys: 2 Growth Stocks to Own for the Long Run (Motley Fool)
May-17-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-24 09:30AM	4 Small-Cap Value Stocks That Could Go Parabolic (Motley Fool)
May-13-24 02:25PM	Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained (MT Newswires)
12:42PM	Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating (MT Newswires)
May-11-24 10:00AM	The 3 Most Undervalued Biotech Stocks to Buy in May 2024 (InvestorPlace)
May-10-24 02:03PM	Why Iovance Stock Is Down 18% Today (Motley Fool) -18.48%
01:35PM	Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says (MT Newswires)
12:55PM	Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ... (GuruFocus.com)
12:33PM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:25AM	Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates (MT Newswires)
10:58AM	Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates (Zacks)
May-09-24 08:57PM	IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:27PM	Iovance Biotherapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:23PM	Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours (MT Newswires)
04:01PM	Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates (GlobeNewswire)
May-06-24 09:56AM	Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect (Zacks)
May-01-24 06:01AM	Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024 (GlobeNewswire) +6.11%
Apr-30-24 06:01AM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire)
Apr-28-24 02:44PM	Where Will Iovance Biotherapeutics Stock Be in 5 Years? (Motley Fool)
Apr-27-24 07:00AM	The Top 3 Biotech Stocks to Buy in April 2024 (InvestorPlace)
Apr-25-24 10:30AM	3 Millionaire-Maker Biotech Stocks (Motley Fool)
09:20AM	20 Counties with the Highest Cancer Rates in the US (Insider Monkey)
Apr-24-24 04:01PM	Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting (GlobeNewswire)
Apr-21-24 05:08AM	These Biotech Stocks Could Soar 120% and 295%, According to Wall Street (Motley Fool)
Apr-19-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-17-24 09:45AM	Is Iovance Biotherapeutics Stock a Buy Now? (Motley Fool)
Apr-08-24 01:51PM	Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why (Zacks)
Apr-05-24 05:03AM	Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics (Motley Fool)
Mar-29-24 11:30AM	Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-26-24 04:11AM	2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street (Motley Fool)
Mar-23-24 09:00AM	U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (The Wall Street Journal)
Mar-22-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-18-24 08:01PM	7 Biotech Stocks Ready to Ride the Sectors Resurgence (InvestorPlace)
02:00AM	Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead (Motley Fool)
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 06:01AM	1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17? (Motley Fool)
Mar-06-24 04:42AM	Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst (Motley Fool)
Mar-05-24 01:00PM	FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study (Zacks)
Mar-04-24 06:30AM	Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer (GlobeNewswire)
Mar-02-24 06:50AM	Could Iovance Biotherapeutics Stock Help You Become a Millionaire? (Motley Fool)
Mar-01-24 05:00PM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire) +5.53%
Feb-29-24 05:47PM	Why Iovance Biotherapeutics Stock Got Trounced on Thursday (Motley Fool) -8.72%
12:17PM	Q4 2023 Iovance Biotherapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
10:37AM	Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates (Zacks)
09:44AM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:51AM	Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy? (Motley Fool)
Feb-28-24 05:35PM	Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:42PM	Iovance Biotherapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:35PM	Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:01PM	Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-27-24 08:52AM	Why Iovance (IOVA) Might Surprise This Earnings Season (Zacks) +5.24%
Feb-26-24 05:39AM	1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street (Motley Fool) +5.26%
Feb-25-24 08:07AM	Insiders Pour Millions Into These 2 Buy-Rated Stocks; Heres Why You Might Want to Follow Their Lead (TipRanks)
05:01AM	Is Iovance a Buy After Its First Regulatory Win? (Motley Fool)
Feb-23-24 06:14AM	This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst (Motley Fool)
Feb-22-24 08:45AM	Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 (GlobeNewswire)
04:00AM	13 Best Short Squeeze Stocks To Buy Now (Insider Monkey)
Feb-20-24 03:38PM	Iovance Biotherapeutics Stock Rockets 30% Higher (Barrons.com) +31.48%
11:02AM	Why Iovance Biotherapeutics Stock Is Skyrocketing Today (Motley Fool)
08:00AM	WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI (lifileucel) for Advanced Melanoma (PR Newswire)
06:30AM	Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock (GlobeNewswire)
Feb-19-24 08:36AM	Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi (Zacks)
Feb-16-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) -7.29% +31.48%

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vogt Frederick G	Interim CEO & General Counsel	Sep 03 '24	Option Exercise	0.00	57,292	0	212,175	Sep 05 07:56 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Sep 03 '24	Option Exercise	0.00	27,345	0	71,233	Sep 05 07:54 PM
BILINSKY IGOR	Chief Operating Officer	Sep 03 '24	Option Exercise	0.00	26,954	0	66,313	Sep 05 07:53 PM
Bellemin Jean-Marc	Chief Financial Officer	Sep 03 '24	Option Exercise	0.00	23,438	0	41,239	Sep 05 07:52 PM
Vogt Frederick G	Interim CEO & General Counsel	Jul 15 '24	Option Exercise	0.00	20,835	0	168,160	Jul 17 08:01 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jul 15 '24	Option Exercise	0.00	2,813	0	47,299	Jul 17 08:01 PM
BILINSKY IGOR	Chief Operating Officer	Jul 15 '24	Option Exercise	0.00	2,813	0	42,571	Jul 17 08:00 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jun 03 '24	Option Exercise	0.00	3,906	0	46,468	Jun 05 08:07 PM
BILINSKY IGOR	Chief Operating Officer	Jun 03 '24	Option Exercise	0.00	3,516	0	41,542	Jun 05 08:05 PM
Vogt Frederick G	Interim CEO & General Counsel	Jun 03 '24	Option Exercise	0.00	10,417	0	151,751	Jun 05 08:04 PM
Vogt Frederick G	Interim CEO & General Counsel	Apr 15 '24	Option Exercise	0.00	20,834	0	150,185	Apr 17 07:08 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	43,989	Apr 17 07:07 PM
BILINSKY IGOR	Chief Operating Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	39,453	Apr 17 07:07 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Mar 04 '24	Option Exercise	0.00	15,623	0	49,230	Mar 06 06:20 PM
Vogt Frederick G	Interim CEO & General Counsel	Mar 04 '24	Option Exercise	0.00	41,662	0	140,800	Mar 06 06:19 PM
MCPEAK MERRILL A	Director	Feb 20 '24	Buy	9.15	250,000	2,287,500	320,150	Feb 20 07:52 PM
Dukes Iain D.	Director	Feb 20 '24	Buy	9.15	32,000	292,800	54,000	Feb 20 04:21 PM
Rothbaum Wayne P.	Director	Feb 20 '24	Buy	9.15	5,000,000	45,750,000	28,067,333	Feb 20 04:11 PM
Vogt Frederick G	Interim CEO & General Counsel	Jan 16 '24	Option Exercise	0.00	20,834	0	105,668	Jan 18 06:09 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	35,184	Jan 18 06:09 PM
BILINSKY IGOR	Chief Operating Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	31,444	Jan 18 06:07 PM
Vogt Frederick G	Interim CEO & General Counsel	Oct 16 '23	Option Exercise	0.00	20,835	0	93,685	Oct 18 08:05 PM
BILINSKY IGOR	Chief Operating Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	30,026	Oct 18 08:04 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	33,766	Oct 18 08:03 PM
MCPEAK MERRILL A	Director	Sep 18 '23	Buy	5.56	10,000	55,600	248,633	Sep 19 04:30 PM
Rothbaum Wayne P.	Director	Sep 15 '23	Buy	5.30	5,000,000	26,500,000	23,067,333	Sep 15 06:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IOVA

Iovance Biotherapeutics Inc

Upgrade your FINVIZ experience